CADTH Communiqué — Volume 1, No. 1
Welcome to the new CADTH Communiqué — your single information source for news and updates on CADTH’s research, products, and services.
The CADTH Communiqué replaces the COMPUS Communiqué and CDR Update, combining these and our other e-bulletins into one communication tool. The CADTH Communiqué contains the latest CADTH news, including notification of new CADTH health technology assessments, drug formulary recommendations and initiatives, recommendations and tools to support optimal drug usage, opportunities to provide input, and new and emerging health technologies that could significantly impact the health care of Canadians.
Let us know what you think of the CADTH Communiqué! Send us a message at info@cadth.ca. We welcome your feedback!
Diabetes: Optimal Use Tools
Optimal Therapy Newsletter for both the front-line clinician and decision-maker on second- and third-line therapy in type 2 diabetes.
Project in Brief is a one-page summary of CADTH work on second- and third-line therapies for diabetes.
Quick Reference Prescribing Aid for prescribers to consider when they are determining next steps for patients with diabetes after failure of metformin.